WO2001098475A3 - Method for the detection of cathepsins, asparaginyl endopeptidases and isozymes thereof and leukocystatin - Google Patents
Method for the detection of cathepsins, asparaginyl endopeptidases and isozymes thereof and leukocystatin Download PDFInfo
- Publication number
- WO2001098475A3 WO2001098475A3 PCT/EP2001/006791 EP0106791W WO0198475A3 WO 2001098475 A3 WO2001098475 A3 WO 2001098475A3 EP 0106791 W EP0106791 W EP 0106791W WO 0198475 A3 WO0198475 A3 WO 0198475A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- leukocystatin
- cathepsins
- isozymes
- detection
- endopeptidases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Abstract
A method for the selective detection of nucleic acid molecules in biological material, which are specific for cathepsins, asparaginyl endopeptidases and isozymes thereof and for leukocystatin is disclosed and the nucleic acid molecules used in said method and the use thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10030827.9 | 2000-06-23 | ||
DE10030827A DE10030827A1 (en) | 2000-06-23 | 2000-06-23 | Method for the detection of cathepsins, asparaginyl endopeptidase and their isozymes, and of leukocystatin |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001098475A2 WO2001098475A2 (en) | 2001-12-27 |
WO2001098475A3 true WO2001098475A3 (en) | 2002-06-20 |
Family
ID=7646673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/006791 WO2001098475A2 (en) | 2000-06-23 | 2001-06-15 | Method for the detection of cathepsins, asparaginyl endopeptidases and isozymes thereof and leukocystatin |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE10030827A1 (en) |
WO (1) | WO2001098475A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002006530A2 (en) * | 2000-07-13 | 2002-01-24 | Regents Of The University Of Minnesota | Methods and materials for assessing cancer aggressiveness |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0582477A1 (en) * | 1992-08-06 | 1994-02-09 | Tosoh Corporation | Method for diagnosing cancer and pharmaceutical composition |
WO1998034117A1 (en) * | 1997-01-30 | 1998-08-06 | The University Of Liverpool | Cathepsin k and breast cancer |
US5798266A (en) * | 1996-08-27 | 1998-08-25 | K-Quay Enterprises, Llc | Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer |
WO1999063115A2 (en) * | 1998-06-04 | 1999-12-09 | Reprogen, Inc. | Use of cathepsin s in the diagnosis and treatment of endometriosis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998041656A1 (en) * | 1997-03-19 | 1998-09-24 | The Board Of Trustees Of The University Of Arkansas | Compositions and method for the early diagnosis of ovarian cancer |
-
2000
- 2000-06-23 DE DE10030827A patent/DE10030827A1/en not_active Withdrawn
-
2001
- 2001-06-15 WO PCT/EP2001/006791 patent/WO2001098475A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0582477A1 (en) * | 1992-08-06 | 1994-02-09 | Tosoh Corporation | Method for diagnosing cancer and pharmaceutical composition |
US5798266A (en) * | 1996-08-27 | 1998-08-25 | K-Quay Enterprises, Llc | Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer |
WO1998034117A1 (en) * | 1997-01-30 | 1998-08-06 | The University Of Liverpool | Cathepsin k and breast cancer |
WO1999063115A2 (en) * | 1998-06-04 | 1999-12-09 | Reprogen, Inc. | Use of cathepsin s in the diagnosis and treatment of endometriosis |
Also Published As
Publication number | Publication date |
---|---|
WO2001098475A2 (en) | 2001-12-27 |
DE10030827A1 (en) | 2002-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1211324A3 (en) | Amplification and detection of organisms of the chlamydiaceae family | |
WO2003012119A3 (en) | Nucleic acid amplification method | |
WO2001077383A3 (en) | Nucleic acid detection medium | |
WO2004065582A3 (en) | Amplification of dna in a hairpin structure, and applications | |
WO2001048237A3 (en) | Method for quickly detecting microbial dna/rna, kit therefor and the use of said method | |
AU2001259290A1 (en) | Apparatus, method, and computer program product for quantitative analysis of a nucleic acid amplification reaction | |
WO2005010209A3 (en) | Method for the reverse transcription and/or amplification of nucleic acids | |
WO2002004488A3 (en) | Nucleic acid binding polypeptides | |
AU2001287396A1 (en) | Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature | |
AU2001227679A1 (en) | Mutant nucleic binding enzymes and use thereof in diagnostic, detection and purification methods | |
FI953990A (en) | A method of rendering a nucleic acid amplification reaction product incapable of further amplification, a diagnostic assay method using this method, and a test kit and container suitable for performing the method or assay. | |
WO2000066777A3 (en) | Assay based on the analysis of dna melting curves | |
WO2002033129A3 (en) | Nucleic acid amplification controls | |
WO2001066721A3 (en) | Nucleic acid sensor molecules | |
AU2002227305A1 (en) | Micro storage, reaction and detection cells and methods and apparatus for use thereof | |
WO2003048308A3 (en) | Thermus brockianus nucleic acid polymerases | |
ATE403663T1 (en) | NUCLEIC ACID AMPLIFICATION WITH DUPLEX INTERMEDIATE PRODUCTS | |
WO2003048310A3 (en) | Thermus oshimai nucleic acid polymerases | |
HK1040769A1 (en) | Method for detection and quantification of specific nucleic acid. | |
EP1045033A3 (en) | Amplification and detection of shiga-like toxin I producing organisms | |
WO2002090300A8 (en) | Nucleic acids and proteins with thioredoxin reductase activity | |
AU1908100A (en) | Isothermal nucleic acid amplification methods | |
WO2001098475A3 (en) | Method for the detection of cathepsins, asparaginyl endopeptidases and isozymes thereof and leukocystatin | |
AU2001244834A1 (en) | Novel strain for decomposing tmah, and method of wastewater treatment using the same | |
BRPI0001536B8 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
122 | Ep: pct application non-entry in european phase |